Senza categoria Archives - Page 4 of 13 - Elixi International

8 June 2021

Aduhelm (aducanumab), first new Alzheimer’s drug in 20 years.

7 June 2021

Wegovy (semaglutide) injection – first approved drug for chronic weight management since 2014

1 June 2021

Lumakras (sotorasib), first treatment for adult patients with non-small cell lung cancer whose tumors have a specific type of genetic mutation called KRAS G12C

3 May 2021

Farxiga (dapagliflozin) Approved for the treatment of Chronic Kidney Disease

27 April 2021

Enspryng (satralizumab), new treatment for rare autoimmune disease of nerve cells

17 April 2021

Novartis receives EU approval for Kesimpta® (ofatumumab), the first and only self-administered, targeted B-cell therapy for adult patients with relapsing multiple sclerosis

3 April 2021

Abecma (idecabtagene vicleucel), First Cell-Based Gene Therapy for Adult Patients with Multiple Myeloma

23 March 2021

ARCALYST (rilonacept) is the first FDA-approved therapy for recurrent pericarditis

27 February 2021

Evrysdi (Risdiplam), First oral treatment for spinal muscular atrophy (SMA)

14 February 2021

Cosela (trilaciclib), first therapy in its class to reduce the frequency of chemotherapy-induced bone marrow suppression